Free Review Articles on Kidney (Fibrosis)                                 Metatextbook

Freie Reviews über Niere (Fibrose)                                 Look here for Journal Homepages




  • Kidney (Fibrosis)
  • TGF beta
  • Epithelio mesenchymal transition
  • Statin
  • RAAS (AngiotensinII)
  • Kidney (Chronic renal failure)
  • Kidney (Pressure natriuresis)
  • Kidney (Microcirculation)
  • Kidney (Medulla)
  • Redox (BASKET)
  • Nitric oxide NO
  • Aldosterone
  • NADPH oxidase
  • Kidney (Mesangial cell)
  • HIF1alpha und HIF1 (BASKET)
  • Prolyl hydroxylases
  • Cell senescence
  • Diabetes mellitus (Involvement kidney)
  • Macrophages
  • Kidney (Pathology)
  • Kidney (Regeneration)
  • Kidney (Transplantation)
  • Nr.Year

    OPEN

    Titleusers

    say

    rate

    good

    rate

    bad

    no link

    Citation
    12007Epithelial to mesenchymal transition in the progression of tubulointerstitial fibrosis.



    +-nlChin Med J (Engl) 120(21):1925-30 (2007)
    22005Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?



    +-nlAm J Physiol Renal Physiol 289(2):F227-34 (2005)
    32008Slowing nephropathy progression: focus on proteinuria reduction.



    +-nlClin J Am Soc Nephrol 3 Suppl 1(-):S3-10 (2008)
    42008Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.



    +-nlClin J Am Soc Nephrol 3 Suppl 1(-):S17-23 (2008)
    52006Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.



    +-nlClin J Am Soc Nephrol 1(5):1054-65 (2006)
    62004Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure.



    +-nlIntern Med 43(1):9-17 (2004)
    72008Role of mast cells in progressive renal diseases.



    +-nlJ Am Soc Nephrol 19(12):2254-61 (2008)
    82006Renin-angiotensin-aldosterone system and progression of renal disease.



    +-nlJ Am Soc Nephrol 17(11):2985-91 (2006)
    92006How does proteinuria cause progressive renal damage?



    +-nlJ Am Soc Nephrol 17(11):2974-84 (2006)
    102006Renal fibroblasts and myofibroblasts in chronic kidney disease.



    +-nlJ Am Soc Nephrol 17(11):2992-8 (2006)
    112006Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure.



    +-nlJ Am Soc Nephrol 17(1):17-25 (2006)
    122004Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention.



    +-nlJ Am Soc Nephrol 15(1):1-12 (2004)
    132003Chronic progression of tubulointerstitial damage in proteinuric renal disease is mediated by complement activation: a therapeutic role for complement inhibitors?



    +-nlJ Am Soc Nephrol 14(7 Suppl 2):S186-91 (2003)
    141996Molecular insights into renal interstitial fibrosis.



    +-nlJ Am Soc Nephrol 7(12):2495-508 (1996)
    151994Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions.



    +-nlJ Am Soc Nephrol 5(6):1273-87 (1994)
    161992The role of interstitial cells in the progression of renal diseases.



    +-nlJ Am Soc Nephrol 2(10 Suppl):S198-205 (1992)
    172006Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.



    +-nlJ Clin Invest 116(2):288-96 (2006)
    182002BMP-7 and the proximal tubule.



    +-nlKidney Int 61(1):351-2 (2002) Kopp JB
    191999The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?



    +-nlKidney Int 56(5):1627-37 (1999)
    201998The tubulointerstitium in progressive renal disease.



    +-nlKidney Int 54(3):992-4 (1998) Nath KA
    212007Treatment targets in renal fibrosis.



    +-nlNephrol Dial Transplant 22(12):3391-407 (2007)
    222000The importance of tubulointerstitial damage in progressive renal disease.



    +-nlNephrol Dial Transplant 15 Suppl 6(-):76-7 (2000)
    232000Tubulointerstitial damage leads to atubular glomeruli: significance and possible role in progression.



    +-nlNephrol Dial Transplant 15 Suppl 6(-):74-5 (2000)
    242000Morphometry of interstitial fibrosis.



    +-nlNephrol Dial Transplant 15 Suppl 6(-):72-3 (2000)
    252000Apoptosis in tubulointerstitial renal disease.



    +-nlNephrol Dial Transplant 15 Suppl 6(-):55-7 (2000)
    261998Tubulo-interstitial damage in glomerular diseases: its role in the progression of the renal damage.



    +-nlNephrol Dial Transplant 13 Suppl 1(-):80-5 (1998)
    271997Understanding the nature of renal disease progression.



    +-nlKidney Int 51(1):2-15 (1997)
    281994Loss of glomerular function and tubulointerstitial fibrosis: cause or effect?



    +-nlKidney Int 45(2):345-51 (1994)
    291991Mechanisms of tubulointerstitial fibrosis.



    +-nlKidney Int 39(3):550-6 (1991)
    301991The renal tubulointerstitium in diabetes mellitus.



    +-nlKidney Int 39(3):464-75 (1991)
    311990Progression of chronic renal failure in man.



    +-nlKidney Int 37(5):1195-210 (1990)
    321988Preventing the progression of human renal disease: have rational therapeutic principles emerged?



    +-nlKidney Int 33(1):116-28 (1988)
    332002TGF-beta signaling in renal disease.



    +-nlJ Am Soc Nephrol 13(10):2600-10 (2002)
    342010New insights into epithelial-mesenchymal transition in kidney fibrosis.



    +-nlJ Am Soc Nephrol 21(2):212-22 (2010)
    352005Are 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors renoprotective?



    +-nlJ Am Soc Nephrol 16 Suppl 1(-):S11-7 (2005)
    362011Capillary rarefaction, hypoxia, VEGF and angiogenesis in chronic renal disease.



    +-nlNephrol Dial Transplant 26(4):1132-7 (2011)
    372006Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla.



    +-nlJ Pharmacol Sci 100(1):2-8 (2006)
    382006Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade.



    +-nlJ Pharmacol Sci 100(1):9-16 (2006)
    392011Pathophysiological roles of aldosterone and mineralocorticoid receptor in the kidney.



    +-nlJ Pharmacol Sci 115(1):1-7 (2011)
    402008Possible underlying mechanisms responsible for aldosterone and mineralocorticoid receptor-dependent renal injury.



    +-nlJ Pharmacol Sci 108(4):399-405 (2008)
    412009Drug discovery for overcoming chronic kidney disease (CKD): prolyl-hydroxylase inhibitors to activate hypoxia-inducible factor (HIF) as a novel therapeutic approach in CKD.



    +-nlJ Pharmacol Sci 109(1):24-31 (2009)
    422011Replicative senescence in kidney aging, renal disease, and renal transplantation.



    +-nlDiscov Med 11(56):65-75 (2011)
    432010Diabetic nephropathy -- a multifaceted target of new therapies.



    +-nlDiscov Med 10(54):406-15 (2010)
    442008Macrophage diversity in renal injury and repair.



    +-nlJ Clin Invest 118(11):3522-30 (2008)
    452007The role of proximal tubular cells in interstitial fibrosis: understanding TGF-beta1.



    +-nlChang Gung Med J 30(1):2-6 (2007)
    462007Oxidative stress as a common pathway to chronic tubulointerstitial injury in kidney allografts.



    +-nlAm J Physiol Renal Physiol 293(2):F445-55 (2007)
    472009Renal tubulointerstitial fibrosis: common but never simple.



    +-nlAm J Physiol Renal Physiol 296(6):F1239-44 (2009)
    482008Modulation of renal inflammation: therapeutic strategies.



    +-nlSaudi J Kidney Dis Transpl 19(1):1-19 (2008)
    492006Renal fibrosis, origin and possible interventions: a time for action.



    +-nlSaudi J Kidney Dis Transpl 17(2):137-48 (2006)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.